EUVIMEDEUVIMED entdecken
Crossref

From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”

Nourhan Shebl, Mohamed Salama iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02739-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Nourhan Shebl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt. Hauptthemen laut MEDLINE: Parkinson Disease, Proteomics, Biomarkers, Metabolomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseProteomicsBiomarkersMetabolomicsDopa DecarboxylaseHumans

Substanzen

BiomarkersDopa Decarboxylase

Autor:innen und Institutionen

  • Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt.
  • Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt. Mohamed-Salama@aucegypt.edu.
  • Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin 2, Ireland. Mohamed-Salama@aucegypt.edu.
  • Faculty of Medicine, Mansoura University, El Mansûra, Egypt. Mohamed-Salama@aucegypt.edu.

ORCID-Profile: Mohamed Salama

Zitieren

APA

Shebl, N., & Salama, M. (2024). From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02739-5

Vancouver

Shebl N, Salama M. From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02739-5

BibTeX
@article{Shebl2024,
  author = {Shebl, Nourhan and Salama, Mohamed},
  title = {From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02739-5}
}
Kostenlos starten →